Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Medicure announces filing of ANDA in collaboration with Apicore
Wednesday, December 14, 2016Medicure Inc a leading Canadian specialty pharmaceutical company is pleased to announce that an abbreviated New Drug Application ANDA was filed with the US Food and Drug Administration for a highvalue cardiovascular generic drug developed as a collab...
Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Movement Disorders
Wednesday, December 14, 2016Sage Therapeutics a clinicalstage biopharmaceutical company developing novel medicines to treat lifealtering central nervous system CNS disorders today announced the initiation of Phase clinical development of SAGE a novel internallydeveloped next g...
Sun Pharma & Moebius Medical sign exclusive global licensing deal to develop MM-II
Tuesday, December 13, 2016Sun Pharma and Israelbased Moebius Medical have entered into an exclusive worldwide licensing deal to further develop MMII a novel pharmaceutical candidate for the treatment of pain in osteoarthritis MMII is a novel nonopioid product that leverages t...
Astellas Pharma to Transfer the exclusive rights for Qutenza to Grünenthal
Tuesday, December 13, 2016Astellas Pharma Inc President and CEO Yoshihiko Hatanaka Astellas today announced that Astellas Pharma Europe Ltd Astellas Pharma Europe has entered into a definitive agreement with Grnenthal under which Astellas Pharma Europe will transfer the exclu...
Sunshine Biopharma Signs Strategic Alliance Agreement With Atlas Pharma
Monday, December 12, 2016Sunshine Biopharma Inc a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications is pleased to announce that it has signed a Strategic Alliance Agreement with...
BioInvent International terminates current BI-505 Phase II study
Monday, December 12, 2016BioInvent International announces that it has decided to terminate its current clinical Phase II study with BI in multiple myeloma The decision follows BioInvents review and discussion with the US Food Drug Administration FDA who put BI on full clin...
FDA has Granted Orphan Drug Designation Request for Biohaven Pharmaceutical's BHV-0223
Saturday, December 10, 2016Biohaven Pharmaceutical Holding Company Ltd announced that the US Food and Drug Administration FDA has granted the Companys orphan drug designation request covering its drug candidate BHV an orally dissolving tablet being developed for the treatment...
AstraZeneca and Lilly enter into agreement to develop MEDI1814 for potential disease-modifying treatment for Alzheimer’s disease (AD)
Saturday, December 10, 2016AstraZeneca and Eli Lilly and Company today announced a worldwide agreement to codevelop MEDI an antibody selective for amyloidbeta A which is currently in Phase I trials as a potential diseasemodifying treatment for Alzheimers disease AD This agree...
Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting
Friday, December 09, 2016Eli Lilly and Company NYSE LLY today presented detailed results of its phase EXPEDITION trial at the th Clinical Trials on Alzheimers Disease CTAD meeting As previously disclosed solanezumab did not meet the primary endpoint in the EXPEDITION clinic...
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Friday, December 09, 2016Cardiome Pharma Corp NASDAQ CRME TSX COM announced that it has launched XYDALBA in the UK earlier than expected The European Medicines Agency EMA approved XYDALBA for the treatment of acute bacterial skin and skin structure infections ABSSSI in adul...
